These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 12639162)

  • 1. Pharmacy practitioners' views on computerized documentation of drug-related problems.
    Westerlund LO; Handl WH; Marklund BR; Allebeck P
    Ann Pharmacother; 2003 Mar; 37(3):354-60. PubMed ID: 12639162
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonprescription drug-related problems and pharmacy interventions.
    Westerlund LT; Marklund BR; Handl WH; Thunberg ME; Allebeck P
    Ann Pharmacother; 2001 Nov; 35(11):1343-9. PubMed ID: 11724080
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Survey of drug-related problems identified by community pharmacies.
    Hämmerlein A; Griese N; Schulz M
    Ann Pharmacother; 2007 Nov; 41(11):1825-32. PubMed ID: 17925500
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A retrospective analysis of drug-related problems documented in a national database.
    Westerlund T; Gelin U; Pettersson E; Skärlund F; Wågström K; Ringbom C
    Int J Clin Pharm; 2013 Apr; 35(2):202-9. PubMed ID: 23187961
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmaceutical care in community pharmacies: practice and research in Sweden.
    Westerlund LT; Björk HT
    Ann Pharmacother; 2006 Jun; 40(6):1162-9. PubMed ID: 16735653
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GPs' views on patient drug use and the pharmacist's role in DRP management.
    Westerlund T; Brånstad JO
    Pharm World Sci; 2010 Oct; 32(5):562-5. PubMed ID: 20607607
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Nature and frequency of drug-related problems in self-medication (over-the-counter drugs) in daily community pharmacy practice in Germany.
    Eickhoff C; Hämmerlein A; Griese N; Schulz M
    Pharmacoepidemiol Drug Saf; 2012 Mar; 21(3):254-60. PubMed ID: 21953893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Drug-related problems detected in Australian Community Pharmacies: The PROMISe Trial.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Curtain C; Hughes J; Bereznicki LR; Jackson SL; Kong DC; Hughes JD
    Ann Pharmacother; 2011 Sep; 45(9):1067-76. PubMed ID: 21878658
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of the clinical and economic outcomes of pharmacy interventions in drug-related problems.
    Westerlund T; Marklund B
    J Clin Pharm Ther; 2009 Jun; 34(3):319-27. PubMed ID: 19646078
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A clinical knowledge measurement tool to assess the ability of community pharmacists to detect drug-related problems.
    Williams M; Peterson GM; Tenni PC; Bindoff IK
    Int J Pharm Pract; 2012 Aug; 20(4):238-48. PubMed ID: 22775520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Interventions to enhance effective communication during over-the-counter consultations in the community pharmacy setting: A systematic review.
    Seubert LJ; Whitelaw K; Hattingh L; Watson MC; Clifford RM
    Res Social Adm Pharm; 2018 Nov; 14(11):979-988. PubMed ID: 29258734
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Assessing student pharmacist impact on patient over-the-counter medication selection.
    McConaha JL; Finoli LM; Heasley JE; Lunney PD
    J Pharm Pract; 2013 Jun; 26(3):280-7. PubMed ID: 23340915
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Documentation of drug related problems and their management in community pharmacy: Data evolution over six years.
    Amador-Fernández N; Baechler T; Quintana-Bárcena P; Berger J
    Res Social Adm Pharm; 2023 Nov; 19(11):1480-1485. PubMed ID: 37481352
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DOCUMENT: a system for classifying drug-related problems in community pharmacy.
    Williams M; Peterson GM; Tenni PC; Bindoff IK; Stafford AC
    Int J Clin Pharm; 2012 Feb; 34(1):43-52. PubMed ID: 22101425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacists' adoption into practice of newly reclassified medicines from diverse therapeutic areas in Scotland: a quantitative study of factors associated with decision-making.
    Paudyal V; Hansford D; Cunningham S; Stewart D
    Res Social Adm Pharm; 2014; 10(1):88-105. PubMed ID: 23665077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacy beyond the dispensary: general practitioners' views.
    Spencer JA; Edwards C
    BMJ; 1992 Jun; 304(6843):1670-2. PubMed ID: 1633521
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perceived barriers to provision of medication therapy management services (MTMS) and the likelihood of a pharmacist to work in a pharmacy that provides MTMS.
    Blake KB; Madhavan SS
    Ann Pharmacother; 2010 Mar; 44(3):424-31. PubMed ID: 20179254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality supply of nonprescription medicines in Portuguese community pharmacy: An exploratory case study.
    Veiga P; Lapão LV; Cavaco AM; Guerreiro MP
    Res Social Adm Pharm; 2015; 11(6):880-90. PubMed ID: 25662595
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Drug related problems identified by European community pharmacists in patients discharged from hospital.
    Paulino EI; Bouvy ML; Gastelurrutia MA; Guerreiro M; Buurma H;
    Pharm World Sci; 2004 Dec; 26(6):353-60. PubMed ID: 15683106
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nonprescription drug therapy: issues and opportunities.
    Covington TR
    Am J Pharm Educ; 2006 Dec; 70(6):137. PubMed ID: 17332863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.